Evaluation
*
*
*
*
Strongly agreeAgreeNeither agree nor disagreeDisagreeStrongly disagree
Assess the incidence of and clinical markers for classifying advanced prostate cancer (castration-resistant prostate cancer (CRPC)).
Evaluate the importance of the prostate tumor microenvironment, including the role of the immune system, and androgen receptor signaling.
Discuss current treatment approaches for CRPC, including challenges and limitations.
Assess strategies to integrate existing and new therapies into cancer clinical practice for the treatment of advanced prostate cancer.
*
*
*
*
*